Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Ekso Bionics Holdings (EKSO) Leases (2019 - 2026)

Ekso Bionics Holdings has reported Leases over the past 7 years, most recently at $532000.0 for Q4 2025.

  • On a quarterly basis, Leases fell 32.49% to $532000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $532000.0, a 32.49% decrease, with the full-year FY2025 number at $532000.0, down 32.49% from a year prior.
  • Leases reached $532000.0 in Q4 2025 per EKSO's latest filing, down from $632000.0 in the prior quarter.
  • The five-year high for Leases was $1.4 million in Q3 2022, with the low at $92000.0 in Q1 2022.
  • The 5-year median for Leases is $759000.0 (2024), against an average of $753000.0.
  • Peak YoY movement for Leases: tumbled 83.8% in 2022, then soared 1234.78% in 2023.
  • Tracing EKSO's Leases over 5 years: stood at $216000.0 in 2021, then skyrocketed by 505.09% to $1.3 million in 2022, then fell by 25.25% to $977000.0 in 2023, then dropped by 19.34% to $788000.0 in 2024, then plummeted by 32.49% to $532000.0 in 2025.
  • According to Business Quant data, Leases over the past three periods came in at $532000.0, $632000.0, and $730000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.